Name | EC330 |
---|
Description | EC330 is a leukemia inhibitory factor (LIF) inhibitor. |
---|---|
Related Catalog | |
In Vitro | EC330 shows marked specificity in MCF-7 cells overexpressing LIF verses MCF-7 cells. EC330 further shows cytoskeletal disruption and targeting cancer-associated fibroblasts (CAFs) through inhibition of alpha-SMA but not beta-tubulin[1]. |
In Vivo | EC330 treatment (0.1, 0.5 and 2.5 mg/kg) dose dependently reduces tumor burden in ovarian (IGROV-1) and triple negative breast cancer (MDA-MB-231) cell xenografted mouse models as well as MDA-MB-231 PDX models. EC330 exhibits no reactivity towards thiol-cysteine residues, no off target binding to major receptors, kinases or ion channels. EC330 is orally bioavailable and found to be safe and tolerable in toxicity studies[1]. |
References |
Molecular Formula | C30H32F2O2 |
---|---|
Molecular Weight | 462.57 |
Storage condition | 2-8℃ |
Water Solubility | 10 mM in DMSO |